[{"address1": "Bahnhofstrasse 7", "city": "Zug", "zip": "6300", "country": "Switzerland", "phone": "41 41 711 9325", "website": "https://oculis.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.", "fullTimeEmployees": 36, "companyOfficers": [{"maxAge": 1, "name": "Dr. Riad  Sherif M.B.A., M.D.", "age": 56, "title": "CEO & Director", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sylvia  Cheung", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gudrun  Bachmann Ph.D.", "title": "Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ramin  Tadayoni M.D., Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel S. Char J.D.", "age": 63, "title": "Chief Legal Officer", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Virginia R. Dean", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. P\u00e1ll Ragnar J\u00f3hannesson", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Weil", "title": "Chief Commercial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Snehal  Shah Pharm.D.", "title": "President of Research & Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sharon  Klier M.D., M.P.H.", "title": "Chief Development Officer", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 18.7, "open": 20.26, "dayLow": 20.25, "dayHigh": 21.38, "regularMarketPreviousClose": 18.7, "regularMarketOpen": 20.26, "regularMarketDayLow": 20.25, "regularMarketDayHigh": 21.38, "beta": 0.008, "forwardPE": -13.443765, "volume": 349552, "regularMarketVolume": 349552, "averageVolume": 61032, "averageVolume10days": 110190, "averageDailyVolume10Day": 110190, "bid": 21.1, "ask": 21.27, "bidSize": 100, "askSize": 100, "marketCap": 887136704, "fiftyTwoWeekLow": 10.55, "fiftyTwoWeekHigh": 21.38, "priceToSalesTrailing12Months": 1022.0469, "fiftyDayAverage": 16.4854, "twoHundredDayAverage": 13.286805, "currency": "USD", "enterpriseValue": 782906304, "floatShares": 39827597, "sharesOutstanding": 41945000, "sharesShort": 22000, "sharesShortPriorMonth": 24318, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.07226, "heldPercentInstitutions": 0.26612, "shortRatio": 0.55, "shortPercentOfFloat": 0.0007, "impliedSharesOutstanding": 41945000, "bookValue": 2.27, "priceToBook": 9.317181, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -69621000, "trailingEps": -1.81, "forwardEps": -2.24, "enterpriseToRevenue": 901.966, "enterpriseToEbitda": -11.513, "52WeekChange": 0.9421488, "SandP52WeekChange": 0.22263205, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "OCS", "underlyingSymbol": "OCS", "shortName": "Oculis Holding AG", "longName": "Oculis Holding AG", "firstTradeDateEpochUtc": 1621344600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "48d18c2f-9253-3694-a9c9-9afae38b7b9c", "messageBoardId": "finmb_589165623", "gmtOffSetMilliseconds": -18000000, "currentPrice": 21.15, "targetHighPrice": 35.264824, "targetLowPrice": 21.725454, "targetMeanPrice": 29.69266, "targetMedianPrice": 29.625423, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 105473000, "totalCashPerShare": 2.515, "ebitda": -68003000, "totalDebt": 1243000, "quickRatio": 3.862, "currentRatio": 4.022, "totalRevenue": 868000, "debtToEquity": 1.305, "revenuePerShare": 0.022, "returnOnAssets": -0.33455002, "returnOnEquity": -0.69333, "freeCashflow": -26354124, "operatingCashflow": -50158000, "revenueGrowth": -0.014, "operatingMargins": -83.93981, "financialCurrency": "CHF", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]